Annual Accounts Payable
$845.00 K
-$263.00 K-23.74%
31 December 2023
Summary:
Tempest Therapeutics annual accounts payable is currently $845.00 thousand, with the most recent change of -$263.00 thousand (-23.74%) on 31 December 2023. During the last 3 years, it has fallen by -$226.00 thousand (-21.10%). TPST annual accounts payable is now -23.74% below its all-time high of $1.11 million, reached on 31 December 2022.TPST Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.70 M
+$340.00 K+25.06%
30 September 2024
Summary:
Tempest Therapeutics quarterly accounts payable is currently $1.70 million, with the most recent change of +$340.00 thousand (+25.06%) on 30 September 2024. Over the past year, it has increased by +$558.00 thousand (+48.99%). TPST quarterly accounts payable is now -74.65% below its all-time high of $6.70 million, reached on 30 June 2021.TPST Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.7% | +49.0% |
| 3 y3 years | -21.1% | -28.7% |
| 5 y5 years | - | - |
TPST Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -23.7% | at low | -28.7% | +148.1% |
| 5 y | 5 years | -23.7% | at low | -74.7% | +148.1% |
| alltime | all time | -23.7% | at low | -74.7% | +148.1% |
Tempest Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.70 M(+25.1%) |
| June 2024 | - | $1.36 M(+29.1%) |
| Mar 2024 | - | $1.05 M(+24.4%) |
| Dec 2023 | $845.00 K(-23.7%) | $845.00 K(-25.8%) |
| Sept 2023 | - | $1.14 M(+31.2%) |
| June 2023 | - | $868.00 K(-25.0%) |
| Mar 2023 | - | $1.16 M(+4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $1.11 M(+11.8%) | $1.11 M(+19.8%) |
| Sept 2022 | - | $925.00 K(-36.1%) |
| June 2022 | - | $1.45 M(+111.7%) |
| Mar 2022 | - | $684.00 K(-31.0%) |
| Dec 2021 | $991.00 K(-7.5%) | $991.00 K(-58.4%) |
| Sept 2021 | - | $2.38 M(-64.5%) |
| June 2021 | - | $6.70 M(+525.1%) |
| Dec 2020 | $1.07 M | $1.07 M |
FAQ
- What is Tempest Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Tempest Therapeutics?
- What is Tempest Therapeutics annual accounts payable year-on-year change?
- What is Tempest Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly accounts payable year-on-year change?
What is Tempest Therapeutics annual accounts payable?
The current annual accounts payable of TPST is $845.00 K
What is the all time high annual accounts payable for Tempest Therapeutics?
Tempest Therapeutics all-time high annual accounts payable is $1.11 M
What is Tempest Therapeutics annual accounts payable year-on-year change?
Over the past year, TPST annual accounts payable has changed by -$263.00 K (-23.74%)
What is Tempest Therapeutics quarterly accounts payable?
The current quarterly accounts payable of TPST is $1.70 M
What is the all time high quarterly accounts payable for Tempest Therapeutics?
Tempest Therapeutics all-time high quarterly accounts payable is $6.70 M
What is Tempest Therapeutics quarterly accounts payable year-on-year change?
Over the past year, TPST quarterly accounts payable has changed by +$558.00 K (+48.99%)